Near real-time vaccine safety surveillance with partially accrued data

被引:30
|
作者
Greene, Sharon K. [1 ,2 ]
Kulldorff, Martin [1 ,2 ]
Yin, Ruihua [1 ,2 ]
Yih, W. Katherine [1 ,2 ]
Lieu, Tracy A. [1 ,2 ]
Weintraub, Eric S. [3 ]
Lee, Grace M. [1 ,2 ,4 ,5 ]
机构
[1] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02215 USA
[2] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA
[3] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA
[4] Childrens Hosp Boston, Dept Lab Med, Boston, MA USA
[5] Childrens Hosp Boston, Div Infect Dis, Boston, MA USA
关键词
influenza vaccine; near real-time surveillance; quality control; vaccine safety; PROBABILITY RATIO TEST; ADVERSE EVENTS; INFLUENZA;
D O I
10.1002/pds.2133
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose The Vaccine Safety Datalink (VSD) Project conducts near real-time vaccine safety surveillance using sequential analytic methods. Timely surveillance is critical in identifying potential safety problems and preventing additional exposure before most vaccines are administered. For vaccines that are administered during a short period, such as influenza vaccines, timeliness can be improved by undertaking analyses while risk windows following vaccination are ongoing and by accommodating predictable and unpredictable data accrual delays. We describe practical solutions to these challenges, which were adopted by the VSD Project during pandemic and seasonal influenza vaccine safety surveillance in 2009/2010. Methods Adjustments were made to two sequential analytic approaches. The Poisson-based approach compared the number of pre-defined adverse events observed following vaccination with the number expected using historical data. The expected number was adjusted for the proportion of the risk window elapsed and the proportion of inpatient data estimated to have accrued. The binomial-based approach used a self-controlled design, comparing the observed numbers of events in risk versus comparison windows. Events were included in analysis only if they occurred during a week that had already passed for both windows. Results Analyzing data before risk windows fully elapsed improved the timeliness of safety surveillance. Adjustments for data accrual lags were tailored to each data source and avoided biasing analyses away from detecting a potential safety problem, particularly early during surveillance. Conclusions The timeliness of vaccine and drug safety surveillance can be improved by properly accounting for partially elapsed windows and data accrual delays. Copyright c 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:583 / 590
页数:8
相关论文
共 50 条
  • [1] Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
    Kenigsberg, Tat'Yana A.
    Hause, Anne M.
    McNeil, Michael M.
    Nelson, Jennifer C.
    Shoup, Jo Ann
    Goddard, Kristin
    Lou, Yingbo
    Hanson, Kayla E.
    Glenn, Sungching C.
    Weintraub, Eric S.
    [J]. VACCINE, 2022, 40 (22) : 3064 - 3071
  • [2] Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project
    Greene, Sharon K.
    Kulldorff, Martin
    Lewis, Edwin M.
    Li, Rong
    Yin, Ruihua
    Weintraub, Eric S.
    Fireman, Bruce H.
    Lieu, Tracy A.
    Nordin, James D.
    Glanz, Jason M.
    Baxter, Roger
    Jacobsen, Steven J.
    Broder, Karen R.
    Lee, Grace M.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (02) : 177 - 188
  • [3] Near Real-Time Post-Marketing Surveillance: The Experience of the Vaccine Safety Datalink
    Yih, W. K.
    Fireman, B.
    Klein, N.
    Kulldorff, M.
    Lewis, E.
    Lieu, T.
    Weintraub, E.
    Platt, R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S5 - S6
  • [4] Implementing Near Real-Time Vaccine Safety Surveillance Using the Clinical Practice Research Datalink
    Leite, Andreia
    Andrews, Nick
    Thomas, Sara
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 23 - 23
  • [5] Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine
    Donahue, James G.
    Kieke, Burney A.
    Lewis, Edwin M.
    Weintraub, Eric S.
    Hanson, Kayla E.
    McClure, David L.
    Vickers, Elizabeth R.
    Gee, Julianne
    Daley, Matthew F.
    DeStefano, Frank
    Hechter, Rulin C.
    Jackson, Lisa A.
    Klein, Nicola P.
    Naleway, Allison L.
    Nelson, Jennifer C.
    Belongia, Edward A.
    [J]. PEDIATRICS, 2019, 144 (06)
  • [6] Software for prospective near real-time drug safety surveillance
    Maro, Judith C.
    Silva, Ivair R.
    Hou, Laura
    Snyder, Kirk
    Kulldorff, Martin
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 298 - 299
  • [7] Online causal inference with application to near real-time post-market vaccine safety surveillance
    Luo, Lan
    Risk, Malcolm
    Shi, Xu
    [J]. STATISTICS IN MEDICINE, 2024, 43 (14) : 2734 - 2746
  • [8] Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Dataiink (CPRD)
    Leite, Andreia
    Thomas, Sara L.
    Andrews, Nick J.
    [J]. VACCINE, 2017, 35 (49) : 6885 - 6892
  • [9] Real-time vaccine safety surveillance for the early detection of adverse events
    Lieu, Tracy A.
    Kulldorfif, Martin
    Davis, Robert L.
    Lewis, Edwin M.
    Weintraub, Eric
    Yih, Katherine
    Yin, Ruihua
    Brown, Jeffrey S.
    Platt, Richard
    [J]. MEDICAL CARE, 2007, 45 (10) : S89 - S95
  • [10] Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?
    Leite, Andreia
    Thomas, Sara L.
    Andrews, Nick J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (01) : 25 - 29